The key step for the planned synthesis should be the stereoselective introduction of the aryl moiety. The electron-withdrawing Boc group, attached to the amide In the present communication we describe a Michael-type approach using a modified pyroglutamic derivative as the templa te to induce the stereoselectivity. The use of natural ct-amino acids as starting materials for the synthesis of enantiomerically pure compounds has gained interest in recent times since the single chiral center provides a useful building block.7 L-Glutamic acid, the least expensive of all amino acids, is, due to its versatility and availability, one of the most used in synthesis. A simple retrosynthetic analysis (Scheme 2) led us to consider a modified pyroglutamatic acid derivative 28 as a useful starting material for an asymmetric synthesis of (R)-( -)-rolipram (1).
A stereoselective synthesis of (R)-( -)-rolipram from L-glutamic acid is described. The key step is a stereoselective Michael addition of an arylcuprate to a modified pyroglutamic derivative which acts as the template to induce the stereoselectivity. Facile manipulation ofthe enantiomerically pure Michael product afforded the expected therapeutic agent.
(R)-( -)-Rolipram (1), a potent inhibitor of the cardiac cyclic AMP phosphodiesterase (cAMP PDE) enzyme found in brain tissue, is of great interest as a therapeutic agent for the treatment of central nervous system disorders. 1 In a recent paper2 some of the enantioselective syntheses of this compound ha ve been reviewed. In Scheme 1, four retrosynthetic disconnections are shown for (R)-( -)-rolipram (1) . Disconnections a and b are based on the same concept, where a conjugated Michael addition is employed as the key step. Whereas in route a, the stereochemistry of the final product is controlled by the stereoselective conjugate addition of RCuCNLi to a chiral ct,{J-unsaturated bicyclic lactam,3 the diastereoselectivity in route b is controlled by the chirality of the enolate of a N-acetyloxazolidone, which behaves as the nucleophile in the reaction with a suitable nitrostyrene. 4 In route e, two synthetic approaches developed by Mulzer et al., 5 using a suprafacial Claisen rearrangement are summarized. Finally, route d shows the most recent approach which involves an enantioselective deprotonation of a cyclobutanone derivative using (S,S')-ct,ct' -dimethyldibenzylamide as a chiral base.6 nitrogen, activates the tX,f3-unsaturatedsystem toward the conjugate" addition of organocuprates and a bulky protected alcohol 2 (R=CH20SiPh2Bu-t) provides the steric hindrance necessary to control the stereoselectivity in the conjugate addition of the aryl cuprate 3.
The preparation of the chiral doubly protected tX,f3-unsaturated y-Iactam 2 from L-glutamic acid is well documented in the literature. 8 The required bromoarene 43 was obtained in a 4 step synthesis from 2-methoxyphenol via: a) O-benzoylation, b) regioselective electrophylic bromination of the O-protected 2-methoxyphenol, c) deprotection of the benzoyl moiety and finally, d) O-alkylation with cyclopentyl bromide.
The reaction of the aryl cuprate 3, produced in situ from aryl bromide 4, BuLi and a suspension of CuBr·SMe2, with the unsaturated lactam 2 in the presence of trimethylsilyl chloride9 took place in good yield to produce the expected isomer 5 (Scheme 3) where the bulkyl protected silyloxy group induces the newly formed stereocenter, which could be confirmed by 1H NMR spectroscopy (analysis of the crude reaction mixture showed the presence of a single product, de >95%). Standard deprotection of O-Si bond in 5 failed with tetrabutylammonium fluoride/o but triethylammonium fluoridell worked quite well, although a long reaction time was required. The oxidation of the primary alcohol 6 using Jones reagent produced the pyroglutamic acid derivative 7. Decarboxylation12 simultaneously resulted in the deprotection of the Boc group, affording (R)-rolipram (1). Although the direction and magnitude of the optical rotation for this compound is identical to previously reported values, we carried out a chiral HPLC analysis13 for this synthetic material and the racemate, indicating more than 99 % enantiomeric purity. The racemate (±)-1 was simultaneously obtained from achirall-tert-butoxycarbonyl-l ,5-dihydro-2H-pyrrol-2-one (8) 14 by reaction with the aryl cuprate 3.
In conclusion, this work represents an enantioselective synthesis of R-( -)-rolipram using a Michael-type approach from readily available starting materials. The synthesis of alternatively modified pyroglutamic precursors are now in progress in order to shorten the process and results will be reported in due course.
All solvents and reagents were purchased from commercial sources and used as received unless otherwise indicated. Reactions with organometallics were run in flame dried glassware under an argon atmosphere. THF and Et20 were dried over sodium wire and distilled under argon prior to use. 1H NMR and l3c NMR data were recorded on a Varia n Unity (300 MHz) using CDCl3 as solvento Melting points were determined on a Büchi apparatus and are not corrected. Optical rotations were measured with a Perkin-Elmer 241 polarimeter using MeOH as solvento Chromatographic separations were performed by using 230-400 mesh silica gel. (5S)-1-ter t-Bu toxycarbony 1-5-( ter t-bu tyldipheny Isiloxy )methyl-1 ,5-dihydro-2H-pyrrol-2-one (2)8 and 1-tert-butoxycarbonyl-1,5-dihydro-2H-pyrrol-2-one 814 were prepared as described in the literature. Reagents and Conditions CH2Cl2 (2 X 100 mL) and subsequently washed with H20 (2 X 50 mL). The organic layer was dried (MgS04) and on removal of the solvent 2-methoxyphenyl benzoate was obtained as a solid (14.14 g, 51 %); mp 58-60°C.
5-Bromo-2-methoxyphenol:
A solution of Br 2 (10.03 g, 0.063 mol) in AcOH (10 mL) was slowly added to a solution of the above benzoate (13.02 g, 0.057 mol) in AcOH (65 mL). The mixture was stirred at r.t. for 24 h and then more Br2 (3.22 g, 0.020 mol) in the same solvent (15 mL) was added, and the mixture stirred for 24 h. The residue which was obtained by removal of the solvent at r.t. was dissolved in CH2Cl2 (100 mL) and washed with a satd solution of KHC03. The organic layer was dried and evaporated in vacuo to give an oily product which on standing in pentane yielded 5-bromo-2-methoxyphenol as a solid (10.98 g, 70%); mp 62-64°C (Lit.3 mp 60-62°C). (4): To a solution of the above phenol (6.23 g, 0.038 mol) in anhyd DMF (50 mL), were added successively powered anhyd K2C03 (6.36 g, 0.046 mol) and cyclopentyl bromide (6.63 g, 0.046 mol). The mixture was stirred at 60°C for 24 h. The solvent was evaporated in vacuo and the residue triturated with H20 and the inorganic residue removed by filtration. The solution was extracted with CH2Cl2 (40 mL), dried (MgS04) and the solvent was removed in vacuo to yield 4 as an oily product (7.24 g, 87 %), which was used without further purification in the next step. IHNMR 
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Idiphenylsiloxymethyl-4-(3-cyclopentylox y-4-methoxy pheny I)pyrrolidine-2-one (5): To a cooled (-35°C) solution of 4 (1.79 g, 6.6 mmol) in anhyd Et20 was added a 1.6 M solution of BuLi in hexanes (4.13 mL, 6.6 mmol). The precipitate formed was redissolved by the slow addition of anhyd THF and siphoned to a suspension of CuBr'SMe2 (0.682 g, 3.3 mmol) in anhyd Et20 (20 mL). After 1 h the suspension was cooled at -78°C and a solution of 2 (300 mg, 0.66 mmol) and Me3SiCI (0.17 mL, 1.32 mmol) in anhyd Et20 (10 mL) was added. The mixture was stirred for 1.5 h at -78°C, and then quenched with NH4C1 solution. The organic layer was washed with NH4C1 solution, until the blue color of the water phase disappeared, and then dried (MgS04). Evaporation ofthe solvent gave an oily residue which was purified by column chromatography (hexane/EtOAc, 4:1) to furnish 5 (360mg, 84%) as a white solid; mp 46-48°C; (2S,3R)-I-tert-Butoxycarbonyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-5-oxopyrrolidine-2-carboxylic Acid (7): To a solution ofthe alcohol 6 (0.44 g, 1.09 mmol) in acetone (10 mL) was added Jones reagentl5 (1.87 mL) at O°C. The mixture was stirred for 90 min at O°C and for 90 min at r.t. before the addition of propan-2-01 (1 mL). A satd aq solution of NaHC03 (10 mL) was added and the mixture was extracted with EtOAc (3 x 10 mL). The aqueous layer was acidified with 1 N HCI and extracted with EtOAc (3 x 10 mL). The combined organic layers were dried (MgS04) filte red and concentrated in vacuo to give 7 (0. 
4-(3-Cyclopentyloxy
To a solution of acid 7 (60 mg, 0.143 mmol) in anhyd THF (1 mL) under argon at -15°C was added N-methylmorpholine (0.016 mL, 0.143 mmol) and isobutyl chloroformate (0.018 mL, 0.143 mmol). After stirring for 15 min at this temperature, a solution of N-hydroxy-2-thiopyridone (22 mg, 0.172 mmol) and Et3N (0.024 mL, 0.172 mmol) in anhyd THF (1 mL) was added. The mixture was stirred at -15°C under argon, sheltered from light (aluminum foil), for 1 h. The precipitate of N-methylmorpholine hydrochloride was filtered and washed with more anhyd THF under protection from light (aluminum foil). To the filtrate was added tert-butylthiol (0.16 mL, 1.43 mmol) and the mixture was irradiated with two 100 watt tungsten lamps at r.t. under argon in a water bath for 1 h. Et20 (5 mL) was added and the organic layer washed with 0.1 N NaHC03 solution (2 x 5 mL), 0.5 N HCl (2 x 5 mL) and brine (2 x 5 mL). The organic layer was dried (MgS04) and the solvent evaporated. The remaining oil was purified by column chromatography (hexane/EtOAc, 1: 1) to atrord 25 mg (64 %) of a white solid; 
